LPL Financial’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19K Buy
35,099
+7,670
+28% +$4.15K ﹤0.01% 5318
2025
Q1
$18K Sell
27,429
-3,602
-12% -$2.36K ﹤0.01% 5134
2024
Q4
$31.7K Buy
31,031
+16,498
+114% +$16.8K ﹤0.01% 5028
2024
Q3
$12.6K Hold
14,533
﹤0.01% 5009
2024
Q2
$5.21K Buy
14,533
+3,199
+28% +$1.15K ﹤0.01% 4891
2024
Q1
$7.6K Buy
+11,334
New +$7.6K ﹤0.01% 4817
2022
Q4
Sell
-10,671
Closed -$52K 4507
2022
Q3
$52K Buy
+10,671
New +$52K ﹤0.01% 4192
2022
Q1
Sell
-11,498
Closed -$86K 4346
2021
Q4
$86K Sell
11,498
-1,395
-11% -$10.4K ﹤0.01% 4149
2021
Q3
$116K Sell
12,893
-2,132
-14% -$19.2K ﹤0.01% 4079
2021
Q2
$180K Buy
15,025
+2,957
+25% +$35.4K ﹤0.01% 3911
2021
Q1
$151K Sell
12,068
-8,147
-40% -$102K ﹤0.01% 3820
2020
Q4
$315K Sell
20,215
-2,190
-10% -$34.1K ﹤0.01% 3146
2020
Q3
$212K Buy
22,405
+8,499
+61% +$80.4K ﹤0.01% 3141
2020
Q2
$125K Buy
13,906
+1,900
+16% +$17.1K ﹤0.01% 3228
2020
Q1
$76K Buy
12,006
+1,031
+9% +$6.53K ﹤0.01% 3027
2019
Q4
$92K Sell
10,975
-4,650
-30% -$39K ﹤0.01% 3210
2019
Q3
$141K Buy
15,625
+3,200
+26% +$28.9K ﹤0.01% 3094
2019
Q2
$134K Sell
12,425
-700
-5% -$7.55K ﹤0.01% 3104
2019
Q1
$125K Sell
13,125
-3,315
-20% -$31.6K ﹤0.01% 3024
2018
Q4
$189K Buy
16,440
+840
+5% +$9.66K ﹤0.01% 2810
2018
Q3
$264K Buy
15,600
+4,800
+44% +$81.2K ﹤0.01% 2781
2018
Q2
$153K Buy
+10,800
New +$153K ﹤0.01% 3025
2015
Q4
Sell
-32,835
Closed -$200K 3235
2015
Q3
$200K Buy
32,835
+1,150
+4% +$7.01K ﹤0.01% 2513
2015
Q2
$318K Buy
+31,685
New +$318K ﹤0.01% 2258
2014
Q2
Sell
-10,461
Closed -$189K 2739
2014
Q1
$189K Buy
+10,461
New +$189K ﹤0.01% 2462